Many pathogens that either rely on an insect vector to complete their life
cycle (e.g., Trypanosoma spp. and Borrelia spp.) or exist in a unique ecolo
gical niche where transmission from host to host is sporadic (e.g., Neisser
ia spp.) have evolved strategies to maintain infection of their mammalian h
osts for long periods of time in order to ensure their survival. Because th
ey have to survive in the face of a fully functional immune system, a commo
n feature of many of these organisms is their development of sophisticated
strategies for immune evasion. For the above organisms and for malaria para
sites of the genus Plasmodium, a common theme is the ability to undergo clo
nal antigenic variation. In all cases, surface molecules that are important
targets of the humoral immune response are encoded in the genome as multic
opy, nonallelic gene families. Antigenic variation is accomplished by the s
uccessive expression of members of these gene families that show little or
no immunological cross-reactivity. In the case of malaria parasites, howeve
r, some of the molecules that undergo antigenic variation are also major vi
rulence factors, adding an additional level of complication to the host-par
asite interaction. In this review, we cover the history of antigenic variat
ion in malaria and then summarize the more recent data with particular emph
asis on Plasmodium falciparum, the etiological agent of the most severe for
m of human malaria.